Knockout Mouse Project Would Target 500 New Lines Annually
This article was originally published in The Pink Sheet Daily
The advantages of such an effort would include “efficient production with reduced costs; uniform use of knockout methods, allowing for more comparability between knockout mice; and ready access to mice, their derivatives and data,” the group behind the proposed project predicts.
You may also be interested in...
Bayer’s kidney cancer drug brought in $25.2 mil. (€20 mil.) in the first quarter following its approval late last year.
The firm is conducting small studies of short duration after meeting with FDA regarding a May 2005 “approvable” letter.
The company has inked a hospital supply contract for the anesthetic droperidol.